Beth Hecht sold $134K of Xeris Biopharma Holdings, Inc. (XERS) stock

Beth Hecht sold 16,666 shares of XERS stock worth $134K, per an SEC Form 4 filed Jul 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 1, 2026, 1 day before it was made public.

XERS has moved +10.0% since the trade date, from $8.00 to $8.80 (Sep 21, 2026 close).